Carlsmed, Inc. (CARL) vs MapLight Therapeutics, Inc. (MPLT)
A side-by-side comparison of Carlsmed, Inc. and MapLight Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CARL
Carlsmed, Inc.
$14.87HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
MPLT
MapLight Therapeutics, Inc.
$9.87HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — CARL vs MPLT
growth of $100 · dividends reinvested · last 1yCARL +13.0% (+13.0%/yr)MPLT -49.4% (-49.4%/yr)CARL compounded faster over this window
CARL MPLT
CARL vs MPLT: by the numbers
- •MPLT is the larger company ($419M vs $404M market cap).
- •Both run net losses; MPLT's is the smaller (0.00% vs -57.42% net margin).
Metrics side by side
Valuation
| Metric | CARL | MPLT |
|---|---|---|
| P/S ratio | 6.39 | N/A |
| P/B ratio | 4.80 | 1.20 |
Profitability
| Metric | CARL | MPLT |
|---|---|---|
| Gross margin | 76.63% | 0.00% |
| Operating margin | -61.09% | 0.00% |
| Net margin | -57.42% | 0.00% |
| ROE | -43.14% | -65.99% |
| ROIC | -36.54% | -69.35% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.